PortfoliosLab logoPortfoliosLab logo
DVLT vs. RARE
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

DVLT vs. RARE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Datavault AI Inc (DVLT) and Ultragenyx Pharmaceutical Inc. (RARE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, DVLT achieves a -46.08% return, which is significantly lower than RARE's 8.30% return.


DVLT

1D
-2.27%
1M
-11.43%
6M
-49.33%
YTD
-46.08%
1Y
-31.00%
3Y*
-87.95%
5Y*
-90.79%
10Y*
ALL TIME*
-85.13%

RARE

1D
-4.34%
1M
-25.58%
6M
3.49%
YTD
8.30%
1Y
-12.41%
3Y*
-16.59%
5Y*
-20.78%
10Y*
-8.91%
ALL TIME*
-4.76%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Liquidity Comparison


PositionAvg. Volume Value (2W)Avg. Volume Value (1M)Avg. Volume Value (3M)
$4.22M$4.86M$17.20M
$49.66M$56.10M$61.47M

DVLT vs. RARE - Yearly Performance Comparison


2026 (YTD)20252024202320222021202020192018
DVLT
Datavault AI Inc
-46.08%-68.19%-88.31%-98.92%-92.24%-60.73%-70.98%-82.16%-31.60%
RARE
Ultragenyx Pharmaceutical Inc.
8.30%-45.33%-12.02%3.22%-44.90%-39.25%224.12%-1.77%-45.87%

Correlation

The correlation between DVLT and RARE is 0.05, meaning there was essentially no consistent relationship between their historical price movements. Each responded to its own set of market drivers.


Correlation
Correlation (1Y)
Focuses on recent behavior, but can change the most.

0.05

Correlation (3Y)
Balances recent behavior with more history.

0.08

Correlation (5Y)
Shows whether the relationship held over a longer period.

0.09

Correlation (All Time)
Calculated using the full available price history since Jul 27, 2018

0.11

Fundamentals

Market Cap

DVLT:

$96.26M

RARE:

$2.45B

EPS

DVLT:

-$0.44

RARE:

-$6.09

PS Ratio

DVLT:

2.38

RARE:

3.72

Total Revenue (TTM)

DVLT:

$39.38M

RARE:

$669.43M

Gross Profit (TTM)

DVLT:

$15.77M

RARE:

$559.44M

EBITDA (TTM)

DVLT:

-$70.96M

RARE:

-$522.35M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

DVLT vs. RARE — Risk / Return Rank

Compare historical risk-adjusted metric ranks over the past 12 months.

DVLT
DVLT Risk / Return Rank: 4747
Overall Rank
DVLT Sharpe Ratio Rank: 3737
Sharpe Ratio Rank
DVLT Sortino Ratio Rank: 6969
Sortino Ratio Rank
DVLT Omega Ratio Rank: 6262
Omega Ratio Rank
DVLT Calmar Ratio Rank: 3131
Calmar Ratio Rank
DVLT Martin Ratio Rank: 3535
Martin Ratio Rank

RARE
RARE Risk / Return Rank: 4040
Overall Rank
RARE Sharpe Ratio Rank: 3838
Sharpe Ratio Rank
RARE Sortino Ratio Rank: 4242
Sortino Ratio Rank
RARE Omega Ratio Rank: 4444
Omega Ratio Rank
RARE Calmar Ratio Rank: 3939
Calmar Ratio Rank
RARE Martin Ratio Rank: 3838
Martin Ratio Rank
The rank (0–100) uses a weighted average of the Sharpe, Sortino, Omega, Calmar, and Martin percentile ranks for the trailing 12 months. Higher means stronger historical risk-adjusted performance within the peer group.

DVLT vs. RARE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Datavault AI Inc (DVLT) and Ultragenyx Pharmaceutical Inc. (RARE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


DVLTRAREDifference
Sharpe ratioReturn per unit of total volatility

-0.04

Sortino ratioReturn per unit of downside risk

+1.09

Omega ratioGain probability vs. loss probability

1.14

1.05

+0.09

Calmar ratioReturn relative to maximum drawdown

-0.38

-0.18

-0.20

Martin ratioReturn relative to average drawdown

-0.51

-0.34

-0.18

DVLT vs. RARE - Sharpe Ratio Comparison

The current DVLT Sharpe Ratio is -0.17, which is comparable to the RARE Sharpe Ratio of -0.13. The chart below compares the historical Sharpe Ratios of DVLT and RARE, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

DVLT vs. RARE - Drawdown Comparison

The maximum DVLT drawdown since its inception was -100.00%, which is greater than RARE's maximum drawdown of -89.57%. Use the drawdown chart below to compare losses from any high point for DVLT and RARE.


Loading charts...

Drawdown Indicators


DVLTRAREDifference

Max Drawdown

Largest peak-to-trough decline

-100.00%

-89.57%

-10.43%

Max Drawdown (1Y)

Largest decline over 1 year

-90.18%

-49.37%

-40.81%

Max Drawdown (3Y)

Largest decline over 3 years

-99.85%

-68.83%

-31.02%

Max Drawdown (5Y)

Largest decline over 5 years

-100.00%

-81.93%

-18.07%

Max Drawdown (10Y)

Largest decline over 10 years

-89.57%

Current Drawdown

Current decline from peak

-100.00%

-85.96%

-14.04%

Average Drawdown

Average peak-to-trough decline

-90.73%

-55.11%

-35.62%

Ulcer Index

Depth and duration of drawdowns from previous peaks

67.29%

26.28%

+41.01%

Volatility

DVLT vs. RARE - Volatility Comparison

Datavault AI Inc (DVLT) has a higher volatility of 21.29% compared to Ultragenyx Pharmaceutical Inc. (RARE) at 13.46%. This indicates that DVLT's price experiences larger fluctuations and is considered to be riskier than RARE based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


DVLTRAREDifference

Volatility (1M)

Calculated over the trailing 1-month period

21.29%

13.46%

+7.83%

Volatility (6M)

Calculated over the trailing 6-month period

79.00%

38.75%

+40.25%

Volatility (1Y)

Calculated over the trailing 1-year period

204.96%

67.17%

+137.79%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

192.40%

54.65%

+137.75%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

165.33%

55.21%

+110.12%

Dividends

DVLT vs. RARE - Dividend Comparison

Neither DVLT nor RARE has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

DVLT vs. RARE - Financials Comparison

This section allows you to compare key financial metrics between Datavault AI Inc and Ultragenyx Pharmaceutical Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items

Frequently Asked Questions


DVLT and RARE have a correlation of 0.05, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

DVLT has higher volatility (21.29%) compared to RARE (13.46%). In terms of maximum drawdown, DVLT dropped -100.00% vs RARE's -89.57%.

RARE currently has the higher Sharpe Ratio (-0.13 vs -0.17), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for DVLT and RARE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer